Synendos Therapeutics Funding: $31M Raised, Series A (2020)
Synendos Therapeutics is based in Basel, Switzerland. It has raised $31M in total funding. Latest round: Series A.
Synendos Therapeutics funding overview
Synendos Therapeutics is based in Basel, Switzerland. Synendos Therapeutics has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2020. The round record for Synendos Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Kurma Partners, Sunstone Life Science Ventures, BERNINA BioInvest, Schroder Adveq, High-Tech Gründerfonds, Lichtsteiner Foundation and 3 others. 9 distinct backers are named across the disclosed rounds.
Frequently asked about Synendos Therapeutics funding
How much has Synendos Therapeutics raised?
Synendos Therapeutics has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Synendos Therapeutics?
Kurma Partners, Sunstone Life Science Ventures, BERNINA BioInvest, Schroder Adveq, High-Tech Gründerfonds, Lichtsteiner Foundation are named among the investors backing Synendos Therapeutics.
What was the latest Synendos Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2020.
Where is Synendos Therapeutics based?
Synendos Therapeutics is based in Basel, Switzerland.
When did Synendos Therapeutics last raise?
The last disclosed Synendos Therapeutics round closed in January 2020 at Series A.
Synendos Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Basel below to benchmark round size and investor mix.
